Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models
- 1 July 1993
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 15 (3) , 179-184
- https://doi.org/10.1016/0920-1211(93)90054-b
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A benzodiazepine recognition site associated with the non-NMDA glutamate receptorNeuron, 1993
- GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responsesNeuron, 1993
- Probenecid pretreatment enhances anticonvulsant action of NBQX in miceEuropean Journal of Pharmacology, 1992
- GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneuronesNeuroscience Letters, 1991
- The epileptiform activity induced by 4-aminopyridine in rat amygdala slices: antagonism by non-N-methyl-d-aspartate receptor anatagonistsBrain Research, 1990
- 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral IschemiaScience, 1990
- Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466European Journal of Pharmacology, 1989
- Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor AntagonistsScience, 1988
- N-Methyl-d-aspartic acid-induced lethality in mice: selective antagonism by phencylidine-like drugsBrain Research, 1988
- A new device for the rapid measurement of impaired motor function in micePharmacology Biochemistry and Behavior, 1977